The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consensus molecular subtypes, mutational features, and circulating tumor DNA dynamics in colorectal cancer: A real-world clinico-genomic analysis.
 
Imad Shureiqi
No Relationships to Disclose
 
Avinash Ramu
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Vasily Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
J. Bryce Ortiz
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Axel Grothey
Honoraria - Cardinal Health; MECC Global Meetings; Total Health Conferencing
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); Daiichi Sankyo (Inst); Guardant Health (Inst); Lilly (Inst); Merus; Natera (Inst); Replimune (Inst); Revolution Medicines
Research Funding - Caris Life Sciences (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Guardant Health (Inst); Lilly (Inst); Natera (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Cardinal Health; MECC Global Meetings; Total Health Conferencing
 
Michael White
Consulting or Advisory Role - Sentinel Biotherapeutics
 
John Paul Shen
Stock and Other Ownership Interests - Agios; Syndax; Syndax
Consulting or Advisory Role - Engine Biosciences; NaDeNo Nanosciences
Research Funding - BostonGene; Ikena Oncology (Inst)
 
Adham Jurdi
Employment - Natera
Stock and Other Ownership Interests - Agenus; Iovance Biotherapeutics; natera; Verastem
 
Anthony Shields
Consulting or Advisory Role - Caris Life Sciences; Cogent Biosciences; ImaginAb; Legend Biotech
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbisko Therapeutics (Inst); Alkermes (Inst); Amal Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Biohaven Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Caris Life Sciences (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Esperas Pharma (Inst); Esperas Pharma (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Fusion Pharmaceuticals (Inst); Gritstone Bio (Inst); H3 Biomedicine (Inst); Halozyme (Inst); Hutchison China Meditech (Inst); IconOVir Bio (Inst); ImaginAb (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Jiangsu Alphamab Biopharmaceuticals (Inst); Lexicon (Inst); Lilly (Inst); LSK BioPharma (Inst); MSK Pharma (Inst); Nouscom (Inst); Novartis (Inst); Nuvation Bio (Inst); Perspective Therapeutics (Inst); Plexxikon (Inst); Repertoire Immune Medicines (Inst); Seagen (Inst); Shanghai HaiHe Pharmaceutical (Inst); Sorrento Therapeutics (Inst); SQZ Biotechnology (Inst); Taiho Pharmaceutical (Inst); Telix Pharmaceuticals (Inst); TheraBionic (Inst); TopAlliance BioSciences Inc (Inst); Torque (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget